Dr. Alison Ehrlich , MD
Dermatology • Chevy Chase, MD
5530 Wisconsin Ave Ste 530
Chevy Chase, MD 208154451
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on September 20, 2005; this date does not establish years in practice.
-
Published CMS data list 292 Original Medicare Part B services in 2019.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019. Published rows only; this is not a quality measure.
-
Published Part B service records, 2019:
- 17003 — Destruction of precancer skin growth, 2-14 growths: 84 service units.
- 96900 — Application of ultraviolet light to skin: 75 service units.
- 99213 — Established patient outpatient office visit: 57 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2018 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2019). CPT notice
See all 7 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 91 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Fluocinonide — 31 prescription fills, including refills.
- Dupixent Pen (Dupilumab) — 16 prescription fills, including refills.
- Metronidazole — 11 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 6 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 75% of clinicians listed under Dermatology in Chevy Chase, MD (2024, 20 clinicians with data). Median for this group: 263. Middle half: 99 to 421.
Fewer Part D prescriptions than 80% of clinicians listed under Dermatology in Maryland (2024, 254 clinicians with data). Median for this group: 440. Middle half: 163 to 852.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 4,045 in 2017 to 292 in 2019.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2017–2019.
Practice Location & Contact Primary Location
5530 Wisconsin Ave Ste 530
Chevy Chase, MD 208154451
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
George Washington University School Of Medicine
1996
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $14,799 in 2019
The total amount Medicare approved for these services in 2019. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019.
Paid by Medicare
About $8,940 in 2019
The part of the Medicare-allowed amount that Medicare itself paid in 2019, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019.
30-day fills
121 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$259,918 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $213.38 across 10 records.
By nature of payment
- Food and Beverage: $213.38 across 10 records.
Reporting-company totals (3 largest of 5)
- Galderma Laboratories, L.P.: $66.28 across 3 records.
- ABBVIE INC.: $55.06 across 3 records.
- Amgen Inc.: $53.02 across 2 records.
Research and ownership records are not included in these totals; they are in the table below.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
30 years (graduated 1996)
CMS Doctors and Clinicians data list 1996 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Can order Medicare-covered services
CMS lists Dr. Ehrlich as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Chevy Chase and Maryland
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 75% of clinicians listed under Dermatology in Chevy Chase, MD (2024, 20 clinicians with data). Median for this group: 263. Middle half: 99 to 421.
Fewer Part D prescriptions than 80% of clinicians listed under Dermatology in Maryland (2024, 254 clinicians with data). Median for this group: 440. Middle half: 163 to 852.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Dermatology in Chevy Chase, MD (2024, 20 clinicians with data). Median for this group: $11,031. Middle half: $4,057 to $49,598.
A higher Part D drug cost than 75% of clinicians listed under Dermatology in Maryland (2024, 254 clinicians with data). Median for this group: $67,899. Middle half: $8,355 to $207,430.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Ehrlich are from 2019.
25 active clinicians are listed under Dermatology with a practice address in Chevy Chase, MD (345 in Maryland).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Chevy Chase
8% of these 25 clinicians have the CMS telehealth indicator.
72% of these 25 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 93% from 4,045 in 2017 to 292 in 2019.
- 2017: 4,045
- 2018: 2,355
- 2019: 292
-
Medicare-allowed amount
Medicare-allowed amount decreased 85% from $97,433 in 2017 to $14,799 in 2019.
- 2017: $97,433
- 2018: $56,376
- 2019: $14,799
-
Paid by Medicare
Paid by Medicare decreased 88% from $72,353 in 2017 to $8,940 in 2019.
- 2017: $72,353
- 2018: $39,981
- 2019: $8,940
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 250% from 26 in 2020 to 91 in 2024.
- 2020: 26
- 2021: 28
- 2022: 14
- 2023: 80
- 2024: 91
-
30-day fills
30-day fills increased 303% from 30 in 2020 to 121 in 2024.
- 2020: 30
- 2021: 32
- 2022: 14
- 2023: 97
- 2024: 121
-
Part D drug cost
Part D drug cost increased 19894% from $1,300 in 2020 to $259,918 in 2024.
- 2020: $1,300
- 2021: $1,991
- 2022: $151
- 2023: $210,375
- 2024: $259,918
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 99% from $83,865.24 in 2021 to $720.92 in 2025.
- 2021: $83,865.24
- 2022: $53,579.77
- 2023: $39,227.75
- 2024: $27,072.70
- 2025: $720.92
Sources: CMS Medicare Physician & Other Practitioners (2019), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 11 records totaling $720.92.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Eli Lilly and Company |
General
In-kind items and services
|
— | Research | $507.54 |
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
— | General | $28.63 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $26.77 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $26.25 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $21.00 |
| Biofrontera Inc. |
Food and Beverage
In-kind items and services
|
— | General | $20.14 |
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
NEMLUVIO | General | $19.05 |
| Verrica Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
YCANTH | General | $18.88 |
| Galderma Laboratories, L.P. |
Food and Beverage
In-kind items and services
|
— | General | $18.60 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $17.30 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $16.76 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2018 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2019; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
17003
Destruction of precancer skin growth, 2-14 growths
|
84 | 18 | $42.00 | $6.71 |
|
96900
Application of ultraviolet light to skin
|
75 | 15 | $60.00 | $26.41 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
57 | 50 | $170.00 | $85.02 |
|
17000
Destruction of precancer skin growth, 1 growth
|
27 | 25 | $175.00 | $69.60 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
24 | 24 | $240.00 | $124.08 |
|
99202
New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
|
13 | 13 | $163.00 | $87.84 |
|
11102
Biopsy of related skin growth, first growth
|
12 | 12 | $238.00 | $117.46 |
Source: CMS Part B by Provider and Service, 2019; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Fluocinonide | Fluocinonide | 31 | 1,075 | $1,701.49 | 18 |
| Dupixent Pen | Dupilumab | 16 | 448 | $67,791.94 | — |
| Metronidazole | Metronidazole | 11 | 570 | $729.98 | — |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | 320 | $91.01 | — |
| Ketoconazole | Ketoconazole | 11 | 315 | $145.97 | — |
| Tremfya | Guselkumab | 11 | 840 | $189,457.29 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2025-02-05NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
NUCC Taxonomy Code: 207NS0135X
Procedural Dermatology, a subspecialty of Dermatology, encompassing a wide variety of surgical procedures and methods to remove or modify skin tissue for health or cosmetic benefit. These methods include scalpel surgery, laser surgery, chemical surgery, cryosurgery (liquid nitrogen), electrosurgery, aspiration surgery, liposuction, injection of filler substances, and Mohs micrographic controlled surgery (a special technique for the removal of growths, especially skin cancers).
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSSources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 5530 WISCONSIN AVE STE 530, CHEVY CHASE, MD 208154451 (Tel: 2028383016)
Registered at 5530 WISCONSIN AVE STE 530, CHEVY CHASE, MD 208154451 (Tel: 2028383016)
Dermatology (license number reported to NPPES: MD D0055828)
NPI status registered as active in NPPES database
Registered at 6410 ROCKLEDGE DR, STE 201, BETHESDA, MD 208171809 (Tel: 3015308300)
Registered at 6410 ROCKLEDGE DR, STE 201, BETHESDA, MD 208171809 (Tel: 3015308300)
Recorded as ALISON EHRLICH, MD
Dermatology (license number reported to NPPES: MD D0055828)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Chevy Chase
- Dr. Christine Dewitt, MD
- Maral Skelsey
- Caroline Glick, PA-C
- Dr. Mana Ogholikhan, MD
- Dr. Gary Peck, MD
- Laura Monaghan, PA-C, MSM
Mailing Address
5530 Wisconsin Ave Ste 530
Chevy Chase, MD 208154451
Phone: 2028383016